These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17785324)

  • 21. Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA--revival of a disease-activity marker in autoimmune hepatitis.
    Hausdorf G; Roggenbuck D; Feist E; Büttner T; Jungblut PR; Conrad K; Berg C; Klein R
    Clin Chim Acta; 2009 Oct; 408(1-2):19-24. PubMed ID: 19576873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical relevance of autoantibodies after pediatric liver transplantation.
    Richter A; Grabhorn E; Helmke K; Manns MP; Ganschow R; Burdelski M
    Clin Transplant; 2007; 21(3):427-32. PubMed ID: 17488397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. De novo autoimmune hepatitis following liver transplantation: a case report.
    Di Cocco P; Barletta A; Clemente K; D'Angelo M; Greco S; Mazzotta C; Orlando G; Rizza V; Famulari A; Grimaldi A; Pisani F
    Transplant Proc; 2008; 40(6):2073-4. PubMed ID: 18675134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmune hepatitis: Contrasts and comparisons in children and adults - a comprehensive review.
    Floreani A; Liberal R; Vergani D; Mieli-Vergani G
    J Autoimmun; 2013 Oct; 46():7-16. PubMed ID: 24035197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autoimmune hepatitis, from mechanisms to therapy.
    Manns MP; Vogel A
    Hepatology; 2006 Feb; 43(2 Suppl 1):S132-44. PubMed ID: 16447290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and treatment of autoimmune hepatitis.
    Luxon BA
    Gastroenterol Clin North Am; 2008 Jun; 37(2):461-78, vii-viii. PubMed ID: 18499031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoproteomic analysis of potentially severe non-graft-versus-host disease hepatitis after allogenic bone marrow transplantation.
    Beleoken E; Sobesky R; Le Caer JP; Le Naour F; Sebagh M; Moniaux N; Roche B; Mustafa MZ; Guettier C; Johanet C; Samuel D; Bouhris JH; Duclos-Vallee JC; Ballot E
    Hepatology; 2013 Feb; 57(2):689-99. PubMed ID: 22911395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
    Maggiore G; Riva S; Sciveres M
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of target antigens of antiendothelial cell antibodies in healthy individuals: A proteomic approach.
    Servettaz A; Guilpain P; Camoin L; Mayeux P; Broussard C; Tamby MC; Tamas N; Kaveri SV; Guillevin L; Mouthon L
    Proteomics; 2008 Mar; 8(5):1000-8. PubMed ID: 18240136
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antibodies and physiopathogeny of autoimmune hepatitis].
    García-Leiva J; Ríos-Vaca A; Torre-Delgadillo A
    Rev Invest Clin; 2003; 55(5):577-82. PubMed ID: 14968479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of autoimmune hepatitis.
    Vergani D; Mieli-Vergani G
    Pediatr Transplant; 2004 Dec; 8(6):589-93. PubMed ID: 15598331
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Favorable outcomes of autoimmune hepatitis in a community clinic setting.
    Seo S; Toutounjian R; Conrad A; Blatt L; Tong MJ
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1410-4. PubMed ID: 18373564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of antibodies to soluble liver antigen/liver pancreas: a large French study.
    Eyraud V; Chazouilleres O; Ballot E; Corpechot C; Poupon R; Johanet C
    Liver Int; 2009 Jul; 29(6):857-64. PubMed ID: 19302185
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibodies directed against the UDP-glucuronosyltransferases in human autoimmune hepatitis.
    Fabien N; Desbos A; Bienvenu J; Magdalou J
    Autoimmun Rev; 2004 Jan; 3(1):1-9. PubMed ID: 14871643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoantibodies against CYP-2C19: A Novel Serum Marker in Pediatric De Novo Autoimmune Hepatitis?
    Clemente MG; Antonucci R; Mandato C; Cicotto L; Meloni A; Gridelli B; De Virgiliis S; Manns MP; Vajro P
    Biomed Res Int; 2017; 2017():3563278. PubMed ID: 29279846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of the B cell response of patients with anti-liver cytosol autoantibodies in type 2 autoimmune hepatitis.
    Lapierre P; Johanet C; Alvarez F
    Eur J Immunol; 2003 Jul; 33(7):1869-78. PubMed ID: 12811847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glutathione S-transferase T1 genetic mismatch is a risk factor for de novo immune hepatitis in liver transplantation.
    Aguilera I; Sousa JM; Gavilan F; Bernardos A; Wichmann I; Nuñez-Roldan A
    Transplant Proc; 2005 Nov; 37(9):3968-9. PubMed ID: 16386599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. De novo autoimmune hepatitis following liver transplantation for primary biliary cirrhosis.
    Rodríguez-Diaz Y; Reyes-Rodriguez R; Dorta-Francisco MC; Aguilera I; Perera-Molinero A; Moneva-Arce E; Aviles-Ruiz JF
    Transplant Proc; 2006 Jun; 38(5):1467-70. PubMed ID: 16797335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-LC1 autoantibodies in patients with chronic hepatitis C virus infection.
    Béland K; Lapierre P; Marceau G; Alvarez F
    J Autoimmun; 2004 Mar; 22(2):159-66. PubMed ID: 14987745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbonic anhydrase III: a new target for autoantibodies in autoimmune diseases.
    Robert-Pachot M; Desbos A; Moreira A; Becchi M; Tebib J; Bonnin M; Aitsiselmi T; Bienvenu J; Fabien N
    Autoimmunity; 2007 Jul; 40(5):380-9. PubMed ID: 17612900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.